文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

体外前列腺癌模型中透明质酸凝胶与透明质酸酶溶解的评价

Evaluation of hyaluronic acid gel dissolution with hyaluronidase in an in-vitro prostate cancer model.
PubMed 文献 · Clin Transl Radiat Oncol · 2022-01-05

该体外研究用5个模型各植入3 ml透明质酸(HA),分别加入6 ml、3 ml、1.5 ml和0 ml透明质酸酶(HAS,每ml含150国际单位)并用生理盐水补足至6 ml,另设仅植入HA的对照。结果显示HAS浓度越高溶解越快,HA:HAS为1:2时24小时内体积减半,作者认为这对临床误定位后需紧急溶解时有意义。

要点

  • 最高浓度HAS在植入后2小时即观察到最快溶解,第2天体积减少50%,第4天残留不足1 ml(33%)。
  • 其余两种HAS浓度第4天残留不足2 ml(66%),所用HAS量在第7天残留均不足1 ml。
  • 14天后对照模型与仅充生理盐水模型体积稳定在3 ml。

核心结论

  • HAS注射呈现剂量反应关系:HAS体积越高,溶解越快。
  • HA:HAS比例为1:2时,初始体积在24小时内减半。
  • 作者认为这在临床误定位后需紧急溶解时特别有意义。

研究设计与样本

  • 体外研究,应用5个模型,每个植入3 ml HA。
  • HAS剂量为6 ml、3 ml、1.5 ml和0 ml,每ml含150国际单位,各用生理盐水补足至6 ml。
  • 另设一个仅植入3 ml HA的对照模型。
  • 于第1天测4次、第2天测3次、第3天测2次,之后一周每天1次,植入后2周行最终测量。
  • 实验重复进行以排除变异并确认结果。

主要发现

  • 最高浓度HAS在植入后2小时第一个时间点即观察到最快溶解,第2天体积减少50%,第4天残留不足1 ml(33%)。
  • 其余两种HAS浓度也显示体积减少,第4天残留不足2 ml(66%)。
  • 所有所用HAS量在第7天后残留均不足1 ml。
  • 14天后对照模型和充生理盐水模型体积稳定在3 ml。

关键数值与推荐

  • HAS每ml含150国际单位。
  • HA:HAS比例为1:2时,初始体积在24小时内减半。
  • 最高浓度HAS组第4天残留不足1 ml(33%),其余两种浓度组第4天残留不足2 ml(66%)。

临床怎么用

  • 作者认为HA:HAS比例1:2在24小时内体积减半,在临床误定位后需紧急溶解时特别有意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To determine a dose response relationship of disintegration of a hyaluronic acid (HA) and hyaluronidase (HAS) used in prostate cancer radiotherapy. MATERIALS AND METHODS: Five in-vitro models are applicated with 3 ml (ml) HA. For dissolution varying doses of HAS were used: 6 ml, 3 ml, 1.5 ml, and 0 ml. One ml contains 150 International Units (IU). Each HAS was added with saline till the complementary amount of 6 ml. One phantom was solely implanted with a HA 3 ml acting as a control. Length, width and height were measured on different time points: 1st day 4 times, 2nd day 3 times, third day 2 times, and then once daily during one week, with a final measurement 2 weeks after implantation. The experiments were performed in duplicate to exclude variations and confirm the results. RESULTS: The fastest dissolution was observed with the highest concentration of HAS, already observed at the first time point 2 h after implantation, with volume decrease of 50% on the second day, and less than 1 ml residue (33%) on day 4. The 2 other concentrations of HAS also showed a volume decrease, with less than 2 ml (66%) on day 4. All the applied quantities of HAS are observed with a residue of less than 1 ml after 7 days. After 14 days the control phantom and the saline filled one remains on steady state volume (3 ml). CONCLUSIONS: A dose response was observed by HAS injection: highest volumes of HAS dissolute most swiftly. Using a ratio of HA:HAS of 1:2 results in a decrease to half of initial volume within 24 h. This is of special interest when used in clinical practice following erroneous positioning, and dissolution is urgently needed.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Vanneste BGL, Lutgens L, Van Limbergen EJ, et al. Evaluation of hyaluronic acid gel dissolution with hyaluronidase in an in-vitro prostate cancer model. Clin Transl Radiat Oncol. 2022. PMID: 35036588. doi:10.1016/j.ctro.2021.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。